[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338301-105":59,"doc-detail-338301-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","testing-of-rapid-evaporative-mass-spectrometry-for-histological-tissue-classification-and-molecular-diagnostics-in-a-multisite-study-clinical-feasibility-and-cross-site-reproducibility","Testing of rapid evaporative mass spectrometry for histological tissue classification and molecular diagnostics in a multisite study - clinical feasibility and cross-site reproducibility","","Rapid evaporative ionisation mass spectrometry (REIMS) is assessed for multicenter robustness and its ability to support molecular diagnostics of breast tumors. Four sites analyze fresh surgical tissue using identical REIMS setups and protocols, generating cross-comparable datasets. Twenty-one specimens containing pathology-validated tumor and adipose tissues are classified with uni- and multivariate statistics, including analyses of normal, wild-type and PIK3CA mutant ductal carcinomas. Multivariate models achieve 97.1% and 98.6% accuracy in leave-one-site-out and leave-one-patient-out validation.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/testing-of-rapid-evaporative-mass-spectrometry-for-histological-tissue-classification-and-molecular-diagnostics-in-a-multisite-study-clinical-feasibility-and-cross-site-reproducibility/338301/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/testing-of-rapid-evaporative-mass-spectrometry-for-histological-tissue-classification-and-molecular-diagnostics-in-a-multisite-study-clinical-feasibility-and-cross-site-reproducibility/338301.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What question does the study address about REIMS?","Question",{"text":113,"@type":114},"It evaluates whether REIMS can produce robust, cross-comparable datasets across multiple sites for identifying breast tumors and their subtypes, including molecular diagnostics.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was the multicenter experiment designed?",{"text":118,"@type":114},"A consortium of four sites analyzed fresh surgical tissue using identical REIMS setups and protocols, and pathology-validated tumor and adipose tissues were included across 21 specimens.",{"name":120,"@type":111,"acceptedAnswer":121},"How accurate were the multivariate classification models?",{"text":122,"@type":114},"Models built from breast cancer data achieved 97.1% correct classification for leave-one-site-out and 98.6% for leave-one-patient-out cross validation.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},338301,1790441815,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","[www.nature.com/bjc](www.nature.com/bjc British)[ British](www.nature.com/bjc British) Journal of Cancer  \nARTICLE OPEN   \nClinical Studies  \nTesting of rapid evaporative mass spectrometry for histological tissue classiﬁcation and molecular diagnostics in a multisite study  \nMartin Kaufmann1,2, Pierre-Maxence Vaysse3,4,5, Adele Savage6, Loes F. S. Kooreman7,8, Natasja Janssen9, Sonal Varma 10, Kevin Yi Mi Ren10, Shaila Merchant 1, Cecil Jay Engel 1, Steven W. M. Olde Damink4,11,12, Marjolein L. Smidt4,8, Sami Shousha13, Hemali Chauhan6, Evdoxia Karali 14, Emine Kazanc14, George Poulogiannis 14, Gabor Fichtinger9, Boglárka Tauber15, Daniel R. Leff16, Steven D. Pringle17, John F. Rudan 1, Ron M. A. Heeren 3, Tiffany Porta Siegel3, Zoltán Takáts6 and Júlia Balog 6,18 ✉  \n© Waters Technologies Corporation and The Author(s) 2024  \n\n|  | BACKGROUND: While REIMS technology has successfully been demonstrated for the histological identiﬁcation of ex-vivo breast tumor tissues, questions regarding the robustness of the approach and the possibility of tumor molecular diagnostics still remain unanswered. In the current study, we set out to determine whether it is possible to acquire cross-comparable REIMS datasets at multiple sites for the identiﬁcation of breast tumors and subtypes.\u003Cbr>METHODS: A consortium of four sites with three of them having access to fresh surgical tissue samples performed tissue analysis using identical REIMS setups and protocols. Overall, 21 breast cancer specimens containing pathology-validated tumor and adipose tissues were analyzed and results were compared using uni-and multivariate statistics on normal, WT and PIK3CA mutant ductal carcinomas.\u003Cbr>RESULTS: Statistical analysis of data from standards showed signiﬁcant differences between sites and individual users. However, the multivariate classiﬁcation models created from breast cancer data elicited 97 . 1% and 98 .6% correct classiﬁcation for leave-onesite-out and leave-one-patient-out cross validation. Molecular subtypes represented by PIK3CA mutation gave consistent results across sites.\u003Cbr>CONCLUSIONS: The results clearly demonstrate the feasibility of creating and using global classiﬁcation models for a REIMS-based |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| margin assessment tool, supporting the clinical translatability of the approach. |  |  |\n|  | British Journal of Cancer (2024) 131:1298–1308; [https://doi.org/10.1038/s41416-024-02739-y](https://doi.org/10.1038/s41416-024-02739-y) |  |\n|  |  |  |\n\nINTRODUCTION  \nRapid evaporative ionisation mass spectrometry (REIMS) is the functional combination of electrosurgery and on-line mass spectrometric analysis of surgical aerosols [1–3] . Accurate differentiation of cancer versus non-cancerous tissue types by REIMS has been applied to breast [4], colon [5], ovarian [6] and cervical [7] pathologies, and suggests that REIMS could be a valuable tool to support intraoperative decision-making, with  \npotential to improve patient outcomes. The goal of the oncology surgeon is to remove all cancer cells within a margin of noncancerous tissue while minimizing the destruction of noncancerous tissue. Margin status is most often determined postoperatively, sometimes occurring weeks after surgery. While pathologists examine tissue ex vivo at microscopic and cellular levels with up to \u003C1 µm resolution by light microscopy, the surgeons must make intraoperative decisions based on  \n1Department of Surgery, Queen’s University, Kingston, ON, Canada. 2Gastrointestinal Diseases Research Unit, Kingston Health Sciences Centre, Kingston, ON, Canada. 3Maastricht MultiModal Molecular Imaging (M4I) Institute, Division of Imaging Mass Spectrometry, Maastricht University, Maastricht, NL, Netherlands. 4Department of Surgery, Maastricht University Medical Center + (MUMC+), Maastricht, NL, Netherlands. 5Department of Otorhinola","cbCaikiJeU9eXTsV","https://ap.wps.com/l/cbCaikiJeU9eXTsV","pdf",2134451,"English","# Background\n# Methods\n# Results\n# Conclusions\n# Introduction\n## Clinical workflow and rationale","[{\"question\":\"What question does the study address about REIMS?\",\"answer\":\"It evaluates whether REIMS can produce robust, cross-comparable datasets across multiple sites for identifying breast tumors and their subtypes, including molecular diagnostics.\"},{\"question\":\"How was the multicenter experiment designed?\",\"answer\":\"A consortium of four sites analyzed fresh surgical tissue using identical REIMS setups and protocols, and pathology-validated tumor and adipose tissues were included across 21 specimens.\"},{\"question\":\"How accurate were the multivariate classification models?\",\"answer\":\"Models built from breast cancer data achieved 97.1% correct classification for leave-one-site-out and 98.6% for leave-one-patient-out cross validation.\"}]","Testing of rapid evaporative mass spectrometry for histological tissue classification and molecular diagnostics in a multisite study - clinical feasibility and cross-site reproducibility | PDF",1790022963,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/78f8047a85409c2f9c13e9b7af34a072.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0e4bafd6a3985e638729d19506274906.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f4b9b61811274fe8a18a5cb81824fd30.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/941d692fe48bd9a31b8394707f92aad8.webp",980,1301]